Cite

HARVARD Citation

    Golfmann, K. et al. (2018). Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer. Oncogene. 37 (42), pp. 5682-5693. [Online]. 
  
Back to record